BR0312821A - 4-(4-metil-piperazin-1-il-metil)-n-[(4-metil-3-(4-piridin-3-i l)-pirimidin-2-il-amino)-fenil]-benzamida para tratar câncer anaplásico da tireóide - Google Patents

4-(4-metil-piperazin-1-il-metil)-n-[(4-metil-3-(4-piridin-3-i l)-pirimidin-2-il-amino)-fenil]-benzamida para tratar câncer anaplásico da tireóide

Info

Publication number
BR0312821A
BR0312821A BR0312821-0A BR0312821A BR0312821A BR 0312821 A BR0312821 A BR 0312821A BR 0312821 A BR0312821 A BR 0312821A BR 0312821 A BR0312821 A BR 0312821A
Authority
BR
Brazil
Prior art keywords
methyl
piperazin
benzamide
pyrimidin
pyridin
Prior art date
Application number
BR0312821-0A
Other languages
English (en)
Inventor
Alexej Podtcheko
Satoshi Tsuda
Shumichi Yamashita
Akira Ohtsuru
Original Assignee
Akira Ohtsuru
Alexej Podtcheko
Satoshi Tsuda
Shumichi Yamashita
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akira Ohtsuru, Alexej Podtcheko, Satoshi Tsuda, Shumichi Yamashita, Novartis Ag filed Critical Akira Ohtsuru
Publication of BR0312821A publication Critical patent/BR0312821A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"4-(4-METIL-PIPERAZIN-1-IL-METIL)-N-[(4-METIL-3(4-PIRIDIN-3-I L)-PIRIMIDIN-2-IL-AMINO)-FENIL]-BENZAMIDA PARA TRATAR CâNCER ANAPLáSICO DA TIREóIDE". A invenção refere-se ao uso de 4-(4-metil-piperazin-1-il-metil)-N[(4-metil-3-(4-piridin-3-il)-pirimidin-2-il-a mino)-fenil]-benzamida da seguinte fórmula: ou um seu sal farmaceuticamente aceitável para a fabricação de um medicamento para o tratamento de cânceres anaplásicos da tireóide.
BR0312821-0A 2002-07-24 2003-05-23 4-(4-metil-piperazin-1-il-metil)-n-[(4-metil-3-(4-piridin-3-i l)-pirimidin-2-il-amino)-fenil]-benzamida para tratar câncer anaplásico da tireóide BR0312821A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39841002P 2002-07-24 2002-07-24
US45455703P 2003-03-14 2003-03-14
PCT/IB2003/001985 WO2004009088A1 (en) 2002-07-24 2003-05-23 4-(4-methylpiperazin-1-ylmethyl)-n-[4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating anaplastic thyroid cancer

Publications (1)

Publication Number Publication Date
BR0312821A true BR0312821A (pt) 2005-04-19

Family

ID=30773082

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312821-0A BR0312821A (pt) 2002-07-24 2003-05-23 4-(4-metil-piperazin-1-il-metil)-n-[(4-metil-3-(4-piridin-3-i l)-pirimidin-2-il-amino)-fenil]-benzamida para tratar câncer anaplásico da tireóide

Country Status (8)

Country Link
US (1) US20060106026A1 (pt)
EP (1) EP1551408A1 (pt)
JP (1) JP2005533838A (pt)
CN (1) CN1671389A (pt)
AU (1) AU2003232376A1 (pt)
BR (1) BR0312821A (pt)
CA (1) CA2498982A1 (pt)
WO (1) WO2004009088A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115703760B (zh) * 2021-08-11 2024-05-31 山东大学 2,4-二取代嘧啶类细胞周期蛋白依赖性激酶酶抑制剂及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4141219A1 (de) * 1991-12-13 1993-06-17 Basf Ag Verfahren zur herstellung von tetrahydropyrancarbonsaeureestern
CO4940418A1 (es) * 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
ITMI992711A1 (it) * 1999-12-27 2001-06-27 Novartis Ag Composti organici
US20030185831A1 (en) * 2001-11-30 2003-10-02 Schering Corporation Methods of treating cancer using an FPT inhibitor and antineoplastic

Also Published As

Publication number Publication date
JP2005533838A (ja) 2005-11-10
EP1551408A1 (en) 2005-07-13
WO2004009088A1 (en) 2004-01-29
CN1671389A (zh) 2005-09-21
CA2498982A1 (en) 2004-01-29
AU2003232376A1 (en) 2004-02-09
US20060106026A1 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
BR0312873A (pt) 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il) pirimidin-2-ilamino)fenil] benzamida para tratamento de doenças associadas com ret cinase mutante
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
DE50310516D1 (de) Fredericamycin-derivate
BR0114870A (pt) Tratamento de tumores estromais gastrointestinais
BR0109703A (pt) Derivados de piperazina
BR0213233A (pt) Alcinos inibidores de metaloproteinase de matriz
PT998473E (pt) Modificacao da forma de cristal de um derivado de n-fenil-2-pirimidinoamina processos para a sua preparacao e sua utilizacao
BR0312597A (pt) Combinações de drogas para o tratamento de neoplasmas
BR0316169A (pt) Derivados de indolil pirazinona úteis para tratamento de distúrbios e doenças hiperproliferativos associados com angiogênese
BR0210075A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos de tratamento ou profilaxia de doenças ou condições humanas, de distúrbios psicóticos ou distúrbios da debilitação intelectual e de fadiga de vÈo, cessamento de fumar, dependência de nicotina, dores, e para a colite ulcerativa
BR0315337A (pt) Composto, formulação farmacêutica, e, método para tratar câncer
CO5261586A1 (es) Uso de pramipexol en el tratamiento de transtornos de adiccion
BR0309095A (pt) Uso de osteoprotegerina para o tratamento e/ou prevenção de doença fibrótica
EA200701181A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
CY1110712T1 (el) Χρηση ν-(3-μεθοξυ-5-μεθυλπυραζιν-2-υλ)-2-(4-[1,3,4-οξαδιαζολ-2-υλ]φαινυλ)πυριδινο-3-σουλφοναμιδης στη θεραπευτικη αντιμετωπιση του καρκινου
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
PT1390371E (pt) Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores
BRPI0408689A (pt) derivados de benzenosulfonamida, método para preparação e utilização disso para o tratamento da dor
BR0017120A (pt) Composição farmacêutica
TR200101245T2 (tr) N-arilsulfonil-aminoasit-omega-amidler
ATE417608T1 (de) Arzneizusammensetzungen enthaltend modafinilverbindungen
SE0101082D0 (sv) Novel use
CR9074A (es) Agente para la profilaxis o tratamiento del sindrome metabolico
BR0312821A (pt) 4-(4-metil-piperazin-1-il-metil)-n-[(4-metil-3-(4-piridin-3-i l)-pirimidin-2-il-amino)-fenil]-benzamida para tratar câncer anaplásico da tireóide
PT1156805E (pt) Utilizacao de sistenas piliciclicos de tiazole para a fabricacao de medicamentospara a profilaxia ou o tratamento de obesidade

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2157 DE 08/05/2012.